跳至主要内容
临床试验/JPRN-UMIN000003898
JPRN-UMIN000003898尚未招募未知

A randomized study of the influence of proton pump inhibitors on antiplatelet effect by Clopidogrel based on CYP2C19 genotypes - CYP2C19, Clopidgrel and Proton Pump Inhibitor Estimation study(CYCLON study)

ational Cerebral and Cardiovascular Center0 个研究点目标入组 150 人开始时间: 2010年7月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) the patient of severe liver disease 2) the patient of severe renal disease 3) the patient of congenital heart disease 4) the patient of myocardial infarction within 3 months from onset or of severe cardiac function 5) the patient of endocrine disease 6) the patient of malignant or inflammatory disease 7) the patient of severe respiratory disease including idiopathic pulmonary artery hypertension 8) the patient of impaired activities of daily living by neurological or orthopedic disease 9) the patient of severe hypertension 10) the patient who taking corticosteroid or immunosuppressive drug 11) the patient of type 1 diabetes mellitus 12) the patient pregnant or probable of pregnancy 13) the catecholamine injected patient 14) the patient of symptomatic hypotension 15) the patient with left ventricular outflow tract obstruction, hypertrophic obstructive cardiomyopthy or aortic stenosis, effecting hemodynamics significantly 16) the patient who is judged inappropriate for any reason by doctor

研究者

发起方
ational Cerebral and Cardiovascular Center

相似试验